Loading…
Back To Schedule
Wednesday, June 26 • 2:00pm - 3:15pm
#372: Advancing Value and Access With Technology

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Application UAN: 0286-0000-19-695-L04-P; CME 1.25; IACET 1.25; RN 1.25

The purpose of this session is to describe advanced technologies being used to advance value and access through specific, real case examples, in terms of their use for contracting and value assessment. Speakers will describe the technology and use cases associated with blockchain, distributed networks and use of artificial intelligence in outcomes-based contracting among other technological advances.

Learning Objectives

Describe the use of technology to advance value and access; Discuss the use of specific technologies, including blockchain, artificial intelligence, and distributed networks.

Chair

Richard Gliklich, MD

Speaker

The Power of the New Healthcare Data Intelligence
Ian Rentsch, JD

Advancing Outcomes-Based Contracts with AI
Robert A. DiCicco, PharmD



Speakers
avatar for Richard Gliklich

Richard Gliklich

Chief Executive Officer, OM1, United States
Dr. Richard Gliklich is the CEO of OM1, Inc., a real-world data, outcomes and technology company focused on using data and AI to accelerate medical research and personalize medicine, especially in chronic conditions. OM1 develops extensive data networks of participating practices... Read More →
avatar for Ian Rentsch

Ian Rentsch

Chief Executive Officer, Clinerion
Ian Rentsch has over 23 years’ experience in Multinational Corporate Affairs, Outsourcing Management & Clinical Research Development working in large multinational companies including large biopharma and Contract Research Organizations Globally and in Emerging Markets. Most recent... Read More →
avatar for Robert DiCicco

Robert DiCicco

Deputy Chief Health Officer, IBM Watson Health
Rob DiCicco is a Deputy Chief Health Officer for IBM Watson Health where he focuses on Life Sciences. Rob joined IBM in 2018 after a long career in Pharmaceutical R&D spanning nearly 30 years. His area of expertise includes clinical pharmacology and experimental medicine, clinical... Read More →


Wednesday June 26, 2019 2:00pm - 3:15pm PDT
Room 14B San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  12: Value-Access, Session |   05: Patient Engagement, Session